Effectiveness of the postcoital test: randomised controlled trialBMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7157.502 (Published 22 August 1998) Cite this as: BMJ 1998;317:502
- S Guid Oei, gynaecologista,
- Frans M Helmerhorst (), senior lecturerb,
- Kitty W M Bloemenkamp, registrarb,
- Frederieke A M Hollants, medical officerb,
- Debbie E M Meerpoel, medical officerb,
- Marc J N Keirse, professorc
- aDepartment of Obstetrics and Gynaecology, Saint Joseph Hospital, 5500 MB Veldhoven, Netherlands,
- bDepartment of Obstetrics, Gynaecology and Reproductive Medicine, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, Netherlands
- cDepartment of Obstetrics and Gynaecology, Flinders University of South Australia
- Correspondence to: Dr Helmerhorst
- Accepted 13 May 1998
Objectives : To investigate the impact of the postcoital test on the pregnancy rate among subfertile couples and on the number of other diagnostic tests and treatments.
Design : Randomised controlled study.
Setting : A university and two non-university teaching hospitals in the Netherlands.
Subjects : New couples at infertility clinics, 1 March 1993 to 1 October 1995; randomisation to an intervention group (series of infertility investigations that include the postcoital test) or to a control group (series excluding the test).
Main outcome measure : Cumulative pregnancy rate.
Results : Of 736 consecutive new couples, 444 fulfilled the inclusion criteria and consented to participate (intervention group, 227; control group, 217). Treatment was given more often in the intervention group than in the control group (54% v 41%; difference 13% (95% confidence interval 4% to 22%)). Yet cumulative pregnancy rates at 24 months in the intervention group (49% (42% to 55%)) and the control group (48% (42% to 55%)) were closely similar (difference 1% (−9.0% to 9.0%)).
Conclusion : Routine use of the postcoital test in infertility investigations leads to more tests and treatments but has no significant effect on the pregnancy rate.
The postcoital test dates back to 1866
The test is widely used in infertility investigations but has limited diagnostic potential and poor predictive value
Treatments for abnormal test results vary but have not been shown to be effective
This first randomised controlled trial comparing infertility investigations with and without the postcoital test showed closely similar cumulative pregnancy rates at 24 months
Incorporation of the postcoital test in standard infertility investigations increases the number of tests and treatments but has no effect on the pregnancy rate
First introduced in 1866,1 postcoital testing of cervical mucus for the presence of progressively motile sperm has become an important part of infertility investigations. It is used routinely in nearly half of the fertility clinics in Britain and in two thirds of such clinics across Europe.2 Yet observational studies show that the diagnostic and prognostic power of the postcoital test is limited 3 4 —so is its value for assessing and treating cervical hostility to sperm.2 Various treatments are used in cases of abnormal postcoital test results, with intrauterine insemination a clear favourite despite the fact that its effectiveness has not been shown58Theoretically, however, it is possible to find a significant effect of treatment even if it is based on a test with poor diagnostic and prognostic properties. Against this background we conducted a randomised controlled trial comparing infertility investigations with and without postcoital testing to assess the usefulness of such testing for routine fertility investigations.
We compared a series of infertility investigations that routinely included the postcoital test (intervention group) and a series of investigations that excluded the test unless clinicians felt a definite need for it (control group). Cumulative pregnancy rates were the primary outcome of interest. The secondary outcome was the number of other diagnostic tests and treatments in the two groups. To avoid bias clinicians were not told about these secondary outcomes. Apart from the postcoital test, they were free to apply whatever diagnostic tests and treatments they considered to be appropriate.
Patients and randomisation procedure
From 1 March 1993 to 1 October 1995, subfertile couples attending the reproductive medicine units at Leiden University Hospital, Westeinde Hospital (The Hague), and Groene Hart Hospital (Gouda) were candidates for participation in the study. To avoid bias at all subsequent stages, a sequentially numbered, opaque, sealed envelope was assigned to each woman's case notes before she was seen or as soon as a fertility problem was presented. Couples were excluded if the woman had been referred for in vitro fertilisation, donor insemination, intrauterine insemination, or tubal surgery or if she had any health problem unrelated to fertility. If the exclusion criteria did not apply, informed consent was requested. Envelopes for women who were excluded or did not consent were returned to the central randomisation office and discarded unopened.
The study protocol was approved by the institutional review boards of the hospitals. It foresaw predicted a 1:1 randomisation of women to the intervention and control groups.
Postcoital test procedure
The postcoital test was planned 14-16 days before menstruation and 6-18 hours after intercourse. We asked the couples to have intercourse as usual on the night before the test; we gave no instructions on prior abstinence, postcoital rest, or posture. A non-lubricated speculum was used to expose the cervix. Endocervical mucus was collected by suction in a narrow 1 ml disposable syringe. Mucus was considered to be good if it was abundant 0.3 ml), highly ductile 100 mm), and mostly clear to the naked eye
The number of sperms moving forward per high power field (×400 magnification) was recorded. A negative or abnormal (“absent” or “non-motile”) sperm result was considered valid only if the mucus was in good condition or if the test had been repeated and timed by ultrasonic measurement of follicles and serum oestradiol concentration in a later cycle. Positive or normal results were accepted whatever the state of the mucus.
Treatment for negative postcoital test results was in accordance with standard clinical practice.2 Intrauterine insemination was performed with the aid of ovarian stimulation with 100 mg clomiphene citrate daily from days 3 to 7 of the cycle, followed by injection of 10 000 IU human chorionic gonadotrophin (timed by cycle monitoring). This was followed, 40-44 hours later, by intrauterine insemination of sperm after sperm collection with a discontinuous Percoll gradient method. In vitro fertilisation was performed as described by Van de Berg et al.9 Artificial insemination with donor semen was performed after luteinised hormone detection in urine (Ovuquick, Quidel, San Diego, CA) in a natural cycle.
Diagnosis of pregnancy was based on a positive pregnancy test in urine (Pregstik 50/1000, Nourypharma, Oss, Netherlands) 15 days or more after ovulation.
Descriptive statistics were used to assess the similarity of the groups. Cumulative pregnancy rates were calculated as for life table analysis and compared with the Gehan-Wilcoxon test. Categorical data, including cumulative pregnancy rates at 24 months, were assessed by the χ2 test and continuous variables by Student's t test (P<0.05 was considered significant). With the smallest difference in success rate set at 10% (with an α error of 0.05 and a β error of 0.20), 350 couples were required in each arm.
Of 736 consecutive couples with presumed infertility, 287 were excluded according to the criteria, and 5 did not consent (table 2). The remaining 444 couples were randomised to the intervention (n=227) and control (n = 217) groups. The characteristics of the participants did not differ significantly between the two groups (table 22).
Follow up either to pregnancy or for 24 months was complete in both groups. At the end of the study the postcoital test had been performed in 146 of the 227 (64%) couples in the intervention group, with an average frequency of 1.3 times (range 1-4) per couple. Reasons for not performing a postcoital test were pregnancy (n=57), anovulation (n=9), bilateral tubal occlusion (n=9), or azoospermia (n=6). In the control group 3 of the 217 (1%)couples had undergone a postcoital test.
Table 3shows the infertility investigations performed in both groups. Hysterosalpingography was used in 114 (50%) women in the intervention group and in 117 (54%) in the control group. Thirty two (14%) women in the intervention group and 44 (20%) in the control group underwent laparoscopy. Hysterosalpingography was performed 4.7 (range 2.2-8.3) months after the first visit in the intervention group and 3.8 (2.1-7.8) months after the first visit in the control group. The corresponding time intervals for laparoscopy after the first visit were 8.3 (3.4-13.2) months and 6.6 (3.3-12.8) months.
Table 4 shows the treatments for infertility in both groups. Intrauterine insemination was performed in 49 (22%) women in the intervention group, starting 8.4 (3.6-18.3) months after the first visit and in 36 (17%) in the control group, starting 8.6 (3.7-19.2) months after the first visit. Indications for intrauterine insemination in the control group were low sperm count and unexplained infertility. Twenty two (10%) couples in the intervention group and 14 (6%) in the control group underwent in vitro fertilisation. Overall, 122 (54%) couples in the intervention group received treatment, compared with 89 (41%) in the control group, a difference of 13% (95% confidence interval 4% to 22%).
The cumulative pregnancy rate at 24 months was 48% (42% to 55%) in the intervention group and 49% (42% to 55%) in the control group, a difference of 1%−9% to 9%). Pregnancy rates at given times throughout study did not differ significantly either (figure). Analysis based on the couples in the intervention group who underwent the postcoital test and on those in the control group who did not have a postcoital test showed a significantly lower pregnancy rate in the intervention group (53/146 (36%)) than in the control group (105/214 (49%)).Although this represents a difference of 13% (3% to 23%), the difference is partially due to those conceiving before the postcoital test had been performed.
Of the 146 women in the intervention group who underwent the postcoital test, 79 had a normal result, of whom 30 (38%) became pregnant; of the 67 women who had an abnormal result, 23 (34%) conceived, a difference of only 4% −19% to 12%). Of the three control women who underwent a postcoital test, one had a normal result and two an abnormal one; none of them conceived.
We conducted a randomised study to assess the usefulness of the postcoital test in investigating infertility. Because the usefulness of the test was uncertain, 2 10 we justified excluding it from the standard series of infertility investigations. This made it possible to conduct a randomised comparison of two infertility protocols that were identical except for inclusion and exclusion of the postcoital test.
Intention to treat principle
Although 190 postcoital tests were performed in 146 couples in the intervention group, 36% of the 227 couples in that group did not undergo the test. To deal with this and the fact that three couples underwent a postcoital test in the control group, our analysis was based on the groups as randomised, following the “intention to treat” principle.
Original power calculation envisaged 350 couples in each group. In the middle of 1995 changes in staff were foreseen that would affect the daily trial management and the enrolment of couples, and therefore the consistency and reliability of the study. Consequently, we ended enrolment on 1 October 1995, thereby accepting a lower power for the study. By that time 444 subfertile couples were participating, each group containing 130 less than the original power calculations required. Given the absolute equality of a close to 50% pregnancy rate in both groups, a pregnancy rate of about 75% would have been required in the next 130 women in the intervention group to achieve overall significance at the 5% level. The chances of this happening were very small, given a success rate less than 50% in the first 220 women. As the binomial probability of such an occurrence is less than 1 in 100, it is extremely unlikely that continuing the study would have altered the conclusions that can be drawn from it.
More treatments but no effect on pregnancy rate
Except for in vivo and in vitro testing of the interaction between cervical mucus and semen—which are closely linked to the postcoital test (table 3—there were no significant differences in other infertility investigations between the intervention and control groups. Although the results show that the intervention group underwent more treatments than the control group (table 4), the cumulative pregnancy rates at 24 months were closely similar in the two groups. Routine use of the postcoital test in infertility investigations seemed to lead to a larger number of treatments with no effect on the cumulative pregnancy rate.
Poor predictor of fertility
In this study the postcoital test was a poor predictor of fertility. In the intervention group 38% of women with a normal test result conceived, compared with 34% of those with an abnormal result, a difference that is not significant despite the treatments given for abnormal results. These poor test properties are consistent with the findings of meta-analyses and systematic reviews published on this subject. 3 4
The simple availability of a test, fear of missing a crucial diagnosis, and simple zeal for the attainment of diagnostic certainty are all inducements to test what can be tested1113For both clinical and economic reasons it may be wise, however, for every test to be preceded by a conscious decision to test, based on solid evidence that the test is needed. Good arguments exist, too, for not using tests that offer little chance of changing the scope of diagnostic possibilities.14 On the basis of both systematic review of its test properties 3 4 and this randomised trial, it is difficult to justify the postcoital test as an essential procedure in standard infertility investigations.
We thank Professor J P Vandenbroucke for critical reading and advice.
Contributors: SGO initiated and designed the study, reviewed the literature, supervised recruitment at Westeinde and Groene Hart Hospitals, oversaw data collection, analysed data, and jointly wrote the paper with FMH, KWMB, and MJNCK. FMH initiated and designed the study, supervised recruitment at Leiden University Hospital, supervised data collection, and analysed data. KWMB helped to develop the trial and collect data, and analysed data. FAMH and DEMM were responsible for completing data sheets and data entry. Marc Keirse helped in the study design; was responsible for power calculation, central randomisation, and termination of enrolment; reviewed data; and edited the paper.
Funding Financial support was received from the participating institutions only.
Conflict of interest None.